Site search

Donanemab in early symptomatic Alzheimer’s disease Research study

A study to determine the safety and efficacy of a drug called donanemab in treating or delaying the progression of Alzheimer’s dementia.

Benralizumab for moderate to severe atopic dermatitis Research study

A clinical trial to assess the safety and effectiveness of a new drug called benralizumab for atopic dermatitis (eczema).

New drug for moderate to severe hidradenitis suppurativa Research study

A clinical trial to assess the safety and effectiveness of a new drug for hidradenitis suppurativa.

Spesolimab for the treatment of hidradenitis suppurativa Research study

A study to measure how safe and effective spesolimab (the study drug) is in treating participants with moderate to severe hidradenitis suppurativa (HS).

Spesolimab for the treatment of generalised pustular psoriasis Research study

A study to test whether spesolimab prevents flare-ups in patients with generalised pustular psoriasis.

Efgartigimod for the treatment of pemphigus vulgaris or pemphigus foliaceous Research study

A clinical trial to assess how safe and effective the study drug. efgartigimod, is in treating participants with pemphigus who are also receiving oral corticosteroids.

Bimekizumab for the treatment of moderate to severe hidradenitis suppurativa Research study

In this study, we tested whether bimekizumab helps people with a skin disease called hidradenitis suppurativa.

Nemolizumab for the treatment of moderate to severe atopic dermatitis Research study

A clinical trial to assess safety and effectiveness of a new drug for eczema called nemolizumab.

HREC meeting dates & deadlines

The Office for Research has monthly deadlines for submission of new research project applications for review by the RMH Human Research Ethics Committee (HREC).

Ligelizumab for chronic spontaneous urticaria Research study

A clinical trial to assess a new drug called ligelizumab for the treatment of chronic spontaneous urticaria (CSU).